Literature DB >> 20727882

Development and limitations of lentivirus vectors as tools for tracking differentiation in prostate epithelial cells.

Fiona M Frame1, Stefanie Hager, Davide Pellacani, Mike J Stower, Hannah F Walker, Julie E Burns, Anne T Collins, Norman J Maitland.   

Abstract

To investigate hierarchy in human prostate epithelial cells, we generated recombinant lentiviruses, infected primary cultures and cell lines, and followed their fate in vitro. The lentiviruses combined constitutive promoters including CMV and β-actin, or late-stage differentiation promoters including PSCA (prostate stem cell antigen) and PSAPb (prostate specific antigen/probasin) driving expression of monomeric, dimeric and tetrameric fluorescent proteins. Significantly, rare CD133(+) cells from primary prostate epithelial cultures were successfully infected and activation of late-stage promoters was observed in basal epithelial cultures following induction of differentiation. Lentiviruses also infected CD133(+) cells within the P4E6 cell line. However, promoter silencing was observed in several cell lines (P4E6, BPH-1, PC3). We examined the promoter methylation status of the lentiviral insertions in heterogeneously fluorescent cultures from PC3 clones and found that DNA methylation was not the primary mechanism of silencing of the CMV promoter. We also describe limitations to the lentivirus system including technical challenges due to low titers and low infection efficiency in primary cultures. However, we have identified a functional late-stage promoter that indicates differentiation from a basal to a luminal phenotype and demonstrate that this strategy for lineage tracking of prostate epithelial cells is valid with further optimisation.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727882     DOI: 10.1016/j.yexcr.2010.08.004

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  An Endothelial Hsp70-TLR4 Axis Limits Nox3 Expression and Protects Against Oxidant Injury in Lungs.

Authors:  Yi Zhang; Peiying Shan; Anup Srivastava; Ge Jiang; Xuchen Zhang; Patty J Lee
Journal:  Antioxid Redox Signal       Date:  2016-04-22       Impact factor: 8.401

Review 2.  Targeting prostate cancer stem cells for cancer therapy.

Authors:  Guocan Wang; Zhiwei Wang; Fazlul H Sarkar; Wenyi Wei
Journal:  Discov Med       Date:  2012-02       Impact factor: 2.970

3.  DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation.

Authors:  D Pellacani; D Kestoras; A P Droop; F M Frame; P A Berry; M G Lawrence; M J Stower; M S Simms; V M Mann; A T Collins; G P Risbridger; N J Maitland
Journal:  Cell Death Differ       Date:  2014-01-24       Impact factor: 15.828

4.  Lentiviral delivery of RNAi for in vivo lineage-specific modulation of gene expression in mouse lung macrophages.

Authors:  Andrew A Wilson; Letty W Kwok; Emily L Porter; Julie G Payne; Gregory S McElroy; Sarah J Ohle; Sara R Greenhill; Matthew T Blahna; Kazuko Yamamoto; Jyh C Jean; Joseph P Mizgerd; Darrell N Kotton
Journal:  Mol Ther       Date:  2013-02-12       Impact factor: 11.454

5.  Prostate cancer stem cells: do they have a basal or luminal phenotype?

Authors:  Norman J Maitland; Fiona M Frame; Euan S Polson; John L Lewis; Anne T Collins
Journal:  Horm Cancer       Date:  2011-02       Impact factor: 3.869

6.  ETS transcription factor ELF3 (ESE-1) is a cell cycle regulator in benign and malignant prostate.

Authors:  Leanne K Archer; Fiona M Frame; Hannah F Walker; Alastair P Droop; Georgina L K McDonald; Samuel Kucko; Daniel M Berney; Vincent M Mann; Matthew S Simms; Norman J Maitland
Journal:  FEBS Open Bio       Date:  2022-05-06       Impact factor: 2.792

Review 7.  Cellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking Experiments.

Authors:  Amir Mehdi Ansari; A Karim Ahmed; Aerielle E Matsangos; Frank Lay; Louis J Born; Guy Marti; John W Harmon; Zhaoli Sun
Journal:  Stem Cell Rev Rep       Date:  2016-10       Impact factor: 5.739

8.  Lent-On-Plus Lentiviral vectors for conditional expression in human stem cells.

Authors:  Karim Benabdellah; Pilar Muñoz; Marién Cobo; Alejandra Gutierrez-Guerrero; Sabina Sánchez-Hernández; Angélica Garcia-Perez; Per Anderson; Ana Belén Carrillo-Gálvez; Miguel G Toscano; Francisco Martin
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

9.  Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer.

Authors:  Dominika E Butler; Christopher Marlein; Hannah F Walker; Fiona M Frame; Vincent M Mann; Matthew S Simms; Barry R Davies; Anne T Collins; Norman J Maitland
Journal:  Oncotarget       Date:  2017-05-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.